We remain committed to supporting rare disease research, engaging patients and caregivers to understand their unique perspectives, and enhancing our review processes to advance medical products for rare disease patients.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/jo9yEwF
No comments:
Post a Comment